All roads lead to induced pluripotent stem cells: The technologies of iPSC generation

Stem Cells and Development

Volumn 23, Issue 12, 2014, Pages 1285-1300

  Hu, Kejin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CRE RECOMBINASE; MESSENGER RNA; MICRORNA; MINICIRCLE DNA; PLASMID VECTOR; RETROVIRUS VECTOR; VIRUS VECTOR;

ADIPOSE DERIVED STEM CELL; APOPTOSIS; CELL AGING; CISTRON; ELECTROPORATION; EMBRYONIC STEM CELL; ENDOGENOUS RETROVIRUS; EPISOME; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE INSERTION; GENE SILENCING; GENE TECHNOLOGY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN GENOME; LOXP SITE; MUTAGENESIS; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PLASMID; PLURIPOTENT STEM CELL; POINT MUTATION; PRIORITY JOURNAL; PSEUDOTYPING; REPLICON; REVIEW; SENDAI VIRUS; SOMATIC CELL; STEM CELL RESEARCH; TRANSGENE; TRANSIENT TRANSFECTION; TRANSPOSON; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIRION; CELL DIFFERENTIATION; CULTURE TECHNIQUE; CYTOLOGY; GENE EXPRESSION REGULATION; GENE VECTOR;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VECTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; TRANSFECTION;

EID: 84902205262     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0620     Document Type: Review

References (151)

1. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
2. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
3. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
4. Zhao T, ZN Zhang, Z Rong and Y Xu. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474:212-215.
5. Li W, W Wei, S Zhu, J Zhu, Y Shi, T Lin, E Hao, A Hayek, H Deng and S Ding. (2009). Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4:16-19.
6. Liang G, O Taranova, K Xia and Y Zhang. (2010). Butyrate promotes induced pluripotent stem cell generation. J Biol Chem 285:25516-25521.
7. Ichida JK, J Blanchard, K Lam, EY Son, JE Chung, D Egli, KM Loh, AC Carter, FP Di Giorgio, et al. (2009). A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5:491-503.
8. Lyssiotis CA, RK Foreman, J Staerk, M Garcia, D Mathur, S Markoulaki, J Hanna, LL Lairson, BD Charette, et al. (2009). Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci U S A 106:8912-8917.
9. Hou P, Y Li, X Zhang, C Liu, J Guan, H Li, T Zhao, J Ye, WYang, et al. (2013). Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341:651-654.
10. Nakagawa M, N Takizawa, M Narita, T Ichisaka and S Yamanaka. (2010). Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A 107:14152-14157.
11. Nakagawa M, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, K Okita, Y Mochiduki, N Takizawa and S Yamanaka. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101-106.
12. Hu K. (2014). Vectorology and factor delivery in induced pluripotent stem cell reprogramming. Stem Cells Dev [Epub ahead of print]; DOI:10.1089/scd.2013. 0621.
13. Anastasia L, G Pelissero, B Venerando and G Tettamanti. (2010). Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine. Cell Death Differ 17:1230-1237.
14. Feng B, JH Ng, JCD Heng and HH Ng. (2009). Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4:301-312.
15. Xu Y, Y Shi and S Ding. (2008). A chemical approach to stem-cell biology and regenerative medicine. Nature 453:338-344.
16. Li WL and S Ding. (2010). Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci 31:36-45.
17. Li W, K Li, W Wei and S Ding. (2013). Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell 13:270-283.
18. Cepko CW and Pear. (1996). Overview of the retrovirus transduction system. In: Current Protocols in Molecular Biology. Ausubel FM, R Brent, RE Kingston, DD Moore, JG Seidman, JA Smith and K Struhl, eds. John Wiley &Sons, Inc., New York, pp. 9.9.1-9.9.16.
19. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
20. Wernig M, A Meissner, R Foreman, T Brambrink, M Ku, K Hochedlinger, BE Bernstein and R Jaenisch. (2007). In vitro reprogramming of fibroblasts into a pluripotent EScell-like state. Nature 448:318-324.
21. Maherali N, R Sridharan, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, R Yachechko, J Tchieu, et al. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70.
22. Egusa H, K Okita, H Kayashima, GN Yu, S Fukuyasu, M Saeki, T Matsumoto, S Yamanaka and H Yatani. (2010). Gingival fibroblasts as a promising source of induced pluripotent stem cells. PLoS One 5:e12743.
23. Ohta S, Y Imaizumi, Y Okada, W Akamatsu, R Kuwahara, M Ohyama, M Amagai, Y Matsuzaki, S Yamanaka, H Okano and Y Kawakami. (2011). Generation of human melanocytes from induced pluripotent stem cells. PLoS One 6:e16182.
24. Oda Y, Y Yoshimura, H Ohnishi, M Tadokoro, Y Katsube, M Sasao, Y Kubo, K Hattori, S Saito, et al. (2010). Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J Biol Chem 285:29270-29278.
25. Lowry WE, L Richter, R Yachechko, AD Pyle, J Tchieu, R Sridharan, AT Clark and K Plath. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 105:2883-2888.
26. Aasen T and JC Izpisua Belmonte. (2010). Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc 5:371-382.
27. Aasen T, A Raya, MJ Barrero, E Garreta, A Consiglio, F Gonzalez, R Vassena, J Bilic, V Pekarik, et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276-1284.
28. Giorgetti A, N Montserrat, T Aasen, F Gonzalez, I Rodriguez-Piza, R Vassena, A Raya, S Boue, MJ Barrero, et al. (2009). Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5:353-357.
29. Hu K and I Slukvin. (2013). Induction of pluripotent stem cells from umbilical cord blood. In Stem Cells From Biology to Therapy. Meyers RA, ed. Wiley-Blackwell, Singapore, pp. 345-370.
30. WuY,YZhang,AMishra,SD Tardif and PJHornsby. (2010). Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts. Stem Cell Res 4:180-188.
31. Hu K, J Yu, K Suknuntha, S Tian, K Montgomery, KD Choi, R Stewart, JA Thomson and II Slukvin. (2011). Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 117:e109-119.
32. Brown ME, E Rondon, D Rajesh, A Mack, R Lewis, X Feng, LJ Zitur, RD Learish and EF Nuwaysir. (2010). Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLoS One 5: e11373.
33. Panopoulos AD, S Ruiz, F Yi, A Herrerias, EM Batchelder and JC Izpisua Belmonte. (2011). Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells. PLoS One 6:e19743.
34. Sugii S, Y Kida, WT Berggren and RM Evans. (2011). Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc 6:346-358.
35. Sugii S, Y Kida, T Kawamura, J Suzuki, R Vassena, YQ Yin, MK Lutz, WT Berggren, JC Izpisua Belmonte and RM Evans. (2010). Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proc Natl Acad Sci U S A 107:3558-3563.
36. Rodriguez-Piza I, Y Richaud-Patin, R Vassena, F Gonzalez, MJ Barrero, A Veiga, A Raya and JCI Belmonte. (2010). Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. Stem Cells 28:36-44.
37. Park IH, PH Lerou, R Zhao, HG Huo and GQ Daley. (2008). Generation of human-induced pluripotent stem cells. Nat Protoc 3:1180-1186.
38. Hester ME, S Song, CJ Miranda, A Eagle, PH Schwartz and BK Kaspar. (2009). Two factor reprogramming of human neural stem cells into pluripotency. PLoS One 4:e7044.
39. Dimos JT, KT Rodolfa, KK Niakan, LM Weisenthal, H Mitsumoto, W Chung, GF Croft, G Saphier, R Leibel, et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321:1218-1221.
40. Liu H, F Zhu, J Yong, P Zhang, P Hou, H Li, W Jiang, J Cai, M Liu, et al. (2008). Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 3:587-590.
41. Tomioka I, T Maeda, H Shimada, K Kawai, Y Okada, H Igarashi, R Oiwa, T Iwasaki, M Aoki, et al. (2010). Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28. Genes Cells 15:959-969.
42. Zhou T, C Benda, S Dunzinger, Y Huang, JC Ho, J Yang, Y Wang, Y Zhang, Q Zhuang, et al. (2012). Generation of human induced pluripotent stem cells from urine samples. Nat Protoc 7:2080-2089.
43. Zhou T, C Benda, S Duzinger, Y Huang, X Li, Y Li, X Guo, G Cao, S Chen, et al. (2011). Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol 22:1221-1228.
44. Hanna J, S Markoulaki, P Schorderet, BW Carey, C Beard, M Wernig, MP Creyghton, EJ Steine, JP Cassady, et al. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133:250-264.
45. Stadtfeld M, N Maherali, DT Breault and K Hochedlinger. (2008). Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2:230-240.
46. Okano M, DW Bell, DA Haber and E Li. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-257.
47. Wolf D and SP Goff. (2007). TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131:46-57.
48. Zhou HY, SL Wu, JY Joo, SY Zhu, DW Han, TX Lin, S Trauger, G Bien, S Yao, et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4:381-384.
49. Yu J, K Hu, K Smuga-Otto, S Tian, R Stewart, II Slukvin and JA Thomson. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324:797-801.
50. Warren L, PD Manos, T Ahfeldt, YH Loh, H Li, F Lau, W Ebina, PK Mandal, ZD Smith, et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618-630.
51. Okita K, M Nakagawa, HJ Hong, T Ichisaka and S Yamanaka. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953.
52. Seki T, S Yuasa, M Oda, T Egashira, K Yae, D Kusumoto, H Nakata, S Tohyama, H Hashimoto, et al. (2010). Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7:11-14.
53. Hu K and I Slukvin. (2013). Generation of transgene-free iPSC lines from human normal and neoplastic blood cells using episomal vectors. Methods Mol Biol 997:163-176.
54. Lee J, N Sayed, A Hunter, KF Au, WH Wong, ES Mocarski, RR Pera, E Yakubov and JP Cooke. (2012). Activation of innate immunity is required for efficient nuclear reprogramming. Cell 151:547-558.
55. Takahashi K, K Okita, M Nakagawa and S Yamanaka. (2007). Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2:3081-3089.
56. Srinivasakumar N, M Zaboikin, AM Tidball, AA Aboud, MD Neely, KC Ess, AB Bowman and FG Schuening. (2013). Gammaretroviral vector encoding a fluorescent marker to facilitate detection of reprogrammed human fibroblasts during iPSC generation. PeerJ 1:e224.
57. Zhu S, W Li, H Zhou, W Wei, R Ambasudhan, T Lin, J Kim, K Zhang and S Ding. (2010). Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7:651-655.
58. Utikal J, N Maherali, W Kulalert and K Hochedlinger. (2009). Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122:3502-3510.
59. Zhao Y, X Yin, H Qin, F Zhu, H Liu, W Yang, Q Zhang, C Xiang, P Hou, et al. (2008). Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3:475-479.
60. Stadtfeld M, K Brennand and K Hochedlinger. (2008). Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18:890-894.
61. Liao J, C Cui, S Chen, J Ren, J Chen, Y Gao, H Li, N Jia, L Cheng, H Xiao and L Xiao. (2009). Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell 4:11-15.
62. Wu Z, J Chen, J Ren, L Bao, J Liao, C Cui, L Rao, H Li, Y Gu, et al. (2009). Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol 1:46-54.
63. Hanna J, K Saha, B Pando, J van Zon, CJ Lengner, MP Creyghton, A van Oudenaarden and R Jaenisch. (2009). Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462:595-601.
64. Maherali N, T Ahfeldt, A Rigamonti, J Utikal, C Cowan and K Hochedlinger. (2008). A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3:340-345.
65. Eminli S, A Foudi, M Stadtfeld, N Maherali, T Ahfeldt, G Mostoslavsky, H Hock and K Hochedlinger. (2009). Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 41:968-976.
66. Gonzalez F, MB Monasterio, G Tiscornia, NM Pulido, R Vassena, LB Morera, IR Piza and JCI Belmonte. (2009). Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci U S A 106:8918-8922.
67. Si-Tayeb K, FK Noto, A Sepac, F Sedlic, ZJ Bosnjak, JW Lough and SA Duncan. (2010). Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev Biol 10:81.
68. Dickens S, S Van den Berge, B Hendrickx, K Verdonck, A Luttun and JJ Vranckx. (2010). Nonviral transfection strategies for keratinocytes, fibroblasts, and endothelial progenitor cells for ex vivo gene transfer to skin wounds. Tissue Eng Part C Methods 16:1601-1608.
69. Yang F, JJ Green, T Dinio, L Keung, SW Cho, H Park, R Langer and DG Anderson. (2009). Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors. Gene Ther 16:533-546.
70. Montserrat N, E Garreta, F Gonzalez, J Gutierrez, C Eguizabal, V Ramos, S Borros and JCI Belmonte. (2011). Simple generation of human induced pluripotent stem cells using poly-beta-amino esters as the non-viral gene delivery system. J Biol Chem 286:12417-12428.
71. Jia F, KD Wilson, N Sun, DM Gupta, M Huang, Z Li, NJ Panetta, ZY Chen, RC Robbins, et al. (2010). A nonviral minicircle vector for deriving human iPS cells. Nat Methods 7:197-199.
72. Narsinh KH, FJ Jia, RC Robbins, MA Kay, MT Longaker and JC Wu. (2011). Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc 6:78-88.
73. Kim D, CH Kim, JI Moon, YG Chung, MY Chang, BS Han, S Ko, E Yang, KY Cha, R Lanza and KS Kim. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472-476.
74. Cho HJ, CS Lee, YW Kwon, JS Paek, SH Lee, J Hur, EJ Lee, TY Roh, IS Chu, et al. (2010). Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116:386-395.
75. Taranger CK, A Noer, AL Sorensen, AM Hakelien, AC Boquest and P Collas. (2005). Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell 16:5719-5735.
76. Rajasingh J, E Lambers, H Hamada, E Bord, T Thorne, I Goukassian, P Krishnamurthy, KM Rosen, D Ahluwalia, et al. (2008). Cell-free embryonic stem cell extractmediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res 102:e107-117.
77. Walev I, SC Bhakdi, F Hofmann, N Djonder, A Valeva, K Aktories and S Bhakdi. (2001). Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci U S A 98:3185-3190.
78. Fusaki N, H Ban, A Nishiyama, K Saeki and M Hasegawa. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad B Phys 85:348-362.
79. Seki T, S Yuasa and K Fukuda. (2012). Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat Protoc 7:718-728.
80. Nishimura K, M Sano, M Ohtaka, B Furuta, Y Umemura, Y Nakajima, Y Ikehara, T Kobayashi, H Segawa, et al. (2011). Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem 286:4760-4771.
81. Ban H, N Nishishita, N Fusaki, T Tabata, K Saeki, M Shikamura, N Takada, M Inoue, M Hasegawa, et al. (2011). Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperaturesensitive Sendai virus vectors. Proc Natl Acad Sci U S A 108:14234-14239.
82. Macarthur CC, A Fontes, N Ravinder, D Kuninger, J Kaur, M Bailey, A Taliana, MC Vemuri and PT Lieu. (2012). Generation of human-induced pluripotent stem cells by a nonintegrating RNA sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int 2012:564612.
83. Shimazu Y, S Takao, T Irie, K Kiyotani, T Yoshida and T Sakaguchi. (2008). Contribution of the leader sequence to homologous viral interference among Sendai virus strains. Virology 372:64-71.
84. Yonemitsu Y, C Kitson, S Ferrari, R Farley, U Griesenbach, D Judd, R Steel, P Scheid, J Zhu, et al. (2000). Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol 18:970-973.
85. Okada Y. (1993). Sendai virus-induced cell-fusion. Method Enzymol 221:18-41.
86. Angel M and MF Yanik. (2010). Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One 5:e11756.
87. Warren L, Y Ni, J Wang and X Guo. (2012). Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci Rep 2:657.
88. Yakubov E, G Rechavi, S Rozenblatt and D Givol. (2010). Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Biophys Res Commun 394:189-193.
89. Plews JR, J Li, M Jones, HD Moore, C Mason, PW Andrews and J Na. (2010). Activation of pluripotency genes in human fibroblast cells by a novel mRNA based approach. PLoS One 5:e14397.
90. Yoshioka N, E Gros, HR Li, S Kumar, DC Deacon, C Maron, AR Muotri, NC Chi, XD Fu, BD Yu and SF Dowdy. (2013). Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell 13:246-254.
91. Petrakova O, E Volkova, R Gorchakov, S Paessler, RM Kinney and I Frolov. (2005). Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells. J Virol 79:7597-7608.
92. Gorchakov R, E Frolova, BR Williams, CM Rice and I Frolov. (2004). PKR-dependent and-independent mechanisms are involved in translational shutoff during Sindbis virus infection. J Virol 78:8455-8467.
93. Hu K. (2006). Intron exclusion and the mystery of intron loss. FEBS Lett 580:6361-6365.
94. Hu K. (2008). Homologous recombination and innocuous intron elimination In Genetic Recombination Research and Progress. Schulz JH, ed. Nova Biomedical Books, New York, pp. 323-333.
95. Torrents D, M Suyama, E Zdobnov and P Bork. (2003). A genome-wide survey of human pseudogenes. Genome Res 13:2559-2567.
96. Geuking MB, J Weber, M Dewannieux, E Gorelik, T Heidmann, H Hengartner, RM Zinkernagel and L Hangartner. (2009). Recombination of retrotransposon and exogenous RNA virus results in nonretroviral cDNA integration. Science 323:393-396.
97. Belshaw R, AL Dawson, J Woolven-Allen, J Redding, A Burt and M Tristem. (2005). Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J Virol 79:12507-12514.
98. Bannert N and R Kurth. (2004). Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A 101 Suppl 2:14572-14579.
99. Chen G, DR Gulbranson, Z Hou, JM Bolin, V Ruotti, MD Probasco, K Smuga-Otto, SE Howden, NR Diol, et al. (2011). Chemically defined conditions for human iPSC derivation and culture. Nat Methods 8:424-429.
100. Chou BK, P Mali, X Huang, Z Ye, SN Dowey, LM Resar, C Zou, YA Zhang, J Tong and L Cheng. (2011). Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21:518-529.
101. Yu J, KF Chau, MA Vodyanik, J Jiang and Y Jiang. (2011). Efficient feeder-free episomal reprogramming with small molecules. PLoS One 6:e17557.
102. Okita K, Y Matsumura, Y Sato, A Okada, A Morizane, S Okamoto, H Hong, M Nakagawa, K Tanabe, et al. (2011). A more efficient method to generate integration-free human iPS cells. Nat Methods 8:409-412.
103. Marchetto MC, GW Yeo, O Kainohana, M Marsala, FH Gage and AR Muotri. (2009). Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 4:e7076.
104. Kim JB, V Sebastiano, G Wu, MJ Arauzo-Bravo, P Sasse, L Gentile, K Ko, D Ruau, M Ehrich, et al. (2009). Oct4-induced pluripotency in adult neural stem cells. Cell 136:411-419.
105. Kim JB, H Zaehres, G Wu, L Gentile, K Ko, V Sebastiano, MJ Arauzo-Bravo, D Ruau, DW Han, M Zenke and HR Scholer. (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454:646-650.
106. Kirchmaier AL and B Sugden. (1995). Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J Virol 69:1280-1283.
107. Leight ER and B Sugden. (2001). Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol 21:4149-4161.
108. Kameda T, K Smuga-Otto and JA Thomson. (2006). A severe de novo methylation of episomal vectors by human ES cells. Biochem Biophys Res Commun 349:1269-1277.
109. Okita K, T Yamakawa, Y Matsumura, Y Sato, N Amano, A Watanabe, N Goshima and S Yamanaka. (2012). An efficient non-viral method to generate integration-free human iPS cells from cord blood and peripheral blood cells. Stem Cells 31:458-466.
110. Meng X, A Neises, RJ Su, KJ Payne, L Ritter, DS Gridley, J Wang, M Sheng, KH Lau, DJ Baylink and XB Zhang. (2012). Efficient reprogramming of human cord blood CD34 + cells into induced pluripotent stem cells with OCT4 and SOX2 alone. Mol Ther 20:408-416.
111. Camenisch G, M Gruber, G Donoho, P Van Sloun, RH Wenger and M Gassmann. (1996). A polyoma-based episomal vector efficiently expresses exogenous genes in mouse embryonic stem cells. Nucleic Acids Res 24:3707-3713.
112. Gassmann M, G Donoho and P Berg. (1995). Maintenance of an extrachromosomal plasmid vector in mouse embryonic stem cells. Proc Natl Acad Sci U S A 92:1292-1296.
113. Chang CW, YS Lai, KM Pawlik, K Liu, CW Sun, C Li, TR Schoeb and TM Townes. (2009). Polycistronic lentiviral vector for ''Hit and Run'' reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 27:1042-1049.
114. Sommer CA, M Stadtfeld, GJ Murphy, K Hochedlinger, DN Kotton and G Mostoslavsky. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27:543-549.
115. Shao L, W Feng, Y Sun, H Bai, J Liu, C Currie, J Kim, R Gama, Z Wang, et al. (2009). Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 19:296-306.
116. Donnelly ML, G Luke, A Mehrotra, X Li, LE Hughes, D Gani and MD Ryan. (2001). Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol 82:1013-1025.
117. Ryan MD and J Drew. (1994). Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J 13:928-933.
118. Wu Y, DW Melton, Y Zhang and PJ Hornsby. (2009). Improved coinfection with amphotropic pseudotyped retroviral vectors. J Biomed Biotechnol 2009:901079.
119. Kaji K, K Norrby, A Paca, M Mileikovsky, P Mohseni and K Woltjen. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458:771-775.
120. Awe JP, PC Lee, C Ramathal, A Vega-Crespo, J Durruthy-Durruthy, A Cooper, S Karumbayaram, WE Lowry, AT Clark, et al. (2013). Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Stem Cell Res Ther 4:87.
121. Woltjen K, IP Michael, P Mohseni, R Desai, M Mileikovsky, R Hamalainen, R Cowling, W Wang, P Liu, et al. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458:766-770.
122. Yusa K, RRad, J Takeda andABradley. (2009). Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6:363-369.
123. VandenDriessche T, Z Ivics, Z Izsvak and MK Chuah. (2009). Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells. Blood 114:1461-1468.
124. Sarkar A, C Sim, YS Hong, JR Hogan, MJ Fraser, HM Robertson and FH Collins. (2003). Molecular evolutionary analysis of the widespread piggyBac transposon family and related ''domesticated'' sequences. Mol Genet Genomics 270:173-180.
125. Feschotte C. (2006). The piggyBac transposon holds promise for human gene therapy. Proc Natl Acad Sci U S A 103:14981-14982.
126. Mitra R, J Fain-Thornton and NL Craig. (2008). piggyBac can bypass DNA synthesis during cut and paste transposition. EMBO J 27:1097-1109.
127. Li X, RA Harrell, AM Handler, T Beam, K Hennessy and MJ Fraser, Jr. (2005). piggyBac internal sequences are necessary for efficient transformation of target genomes. Insect Mol Biol 14:17-30.
128. O'Malley J, S Skylaki, KA Iwabuchi, E Chantzoura, T Ruetz, A Johnsson, SR Tomlinson, S Linnarsson and K Kaji. (2013). High-resolution analysis with novel cellsurface markers identifies routes to iPS cells. Nature 499:88-91.
129. Wernig M, CJ Lengner, J Hanna, MA Lodato, E Steine, R Foreman, J Staerk, S Markoulaki and R Jaenisch. (2008). A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26:916-924.
130. Hockemeyer D, F Soldner, EG Cook, Q Gao, M Mitalipova and R Jaenisch. (2008). A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 3:346-353.
131. Stadtfeld M, N Maherali, M Borkent and K Hochedlinger. (2010). A reprogrammable mouse strain from genetargeted embryonic stem cells. Nat Methods 7:53-55.
132. Stadtfeld M, M Nagaya, J Utikal, G Weir and K Hochedlinger. (2008). Induced pluripotent stem cells generated without viral integration. Science 322:945-949.
133. Alba R, A Bosch and M Chillon. (2005). Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther 12 Suppl 1:S18-S27.
134. Zhou WB and CR Freed. (2009). Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27:2667-2674.
135. Harui A, S Suzuki, S Kochanek and K Mitani. (1999). Frequency and stability of chromosomal integration of adenovirus vectors. J Virol 73:6141-6146.
136. Filipowicz W, SN Bhattacharyya and N Sonenberg. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102-114.
137. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
138. Anokye-Danso F, M Snitow and EE Morrisey. (2012). How microRNAs facilitate reprogramming to pluripotency. J Cell Sci 125:4179-4187.
139. Leonardo TR, HL Schultheisz, JF Loring and LC Laurent. (2012). The functions of microRNAs in pluripotency and reprogramming. Nat Cell Biol 14:1114-1121.
140. Li ZH, CS Yang, K Nakashima and TM Rana. (2011). Small RNA-mediated regulation of iPS cell generation. EMBO J 30:823-834.
141. Judson RL, JE Babiarz, M Venere and R Blelloch. (2009). Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 27:459-461.
142. Subramanyam D, S Lamouille, RL Judson, JY Liu, N Bucay, R Derynck and R Blelloch. (2011). Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 29:443-448.
143. Liao B, X Bao, L Liu, S Feng, A Zovoilis, W Liu, Y Xue, J Cai, X Guo, et al. (2011). MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition. J Biol Chem 286: 17359-17364.
144. Lin SL, DC Chang, S Chang-Lin, CH Lin, DTS Wu, DT Chen and SY Ying. (2008). Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 14:2115-2124.
145. Anokye-Danso F, CM Trivedi, D Juhr, M Gupta, Z Cui, Y Tian, YZ Zhang, WL Yang, PJ Gruber, JA Epstein and EE Morrisey. (2011). Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8:376-388.
146. Miyoshi N, H Ishii, H Nagano, N Haraguchi, DL Dewi, Y Kano, S Nishikawa, M Tanemura, K Mimori, et al. (2011). Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8:633-638.
147. Lin SL, DC Chang, CH Lin, SY Ying, D Leu and DT Wu. (2011). Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res 39:1054-1065.
148. Chang HM and RI Gregory. (2011). MicroRNAs and reprogramming. Nat Biotechnol 29:499-500.
149. Liu X, H Sun, J Qi, L Wang, S He, J Liu, C Feng, C Chen, W Li, et al. (2013). Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat Cell Biol 15:829-838.
150. Carey BW, S Markoulaki, JH Hanna, DA Faddah, Y Buganim, J Kim, K Ganz, EJ Steine, JP Cassady, et al. (2011). Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9:588-598.
151. Papapetrou EP, MJ Tomishima, SM Chambers, Y Mica, E Reed, J Menon, V Tabar, Q Mo, L Studer and M Sadelain. (2009). Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A 106:12759-12764.